Cargando…
Biomarkers: Tools for Discriminating MODY from Other Diabetic Subtypes
Maturity Onset Diabetes of Young (MODY), characterized by the pancreatic b-cell dysfunction, the autosomal dominant mode of inheritance and early age of onset (often ≤25 years). It differs from normal type 1 and type 2 diabetes in that it occurs at a low rate of 1-5%, three-generational autosomal do...
Autores principales: | Firdous, Parveena, Nissar, Kamran, Masoodi, Shariq Rashid, Ganai, Bashir Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555386/ https://www.ncbi.nlm.nih.gov/pubmed/36248040 http://dx.doi.org/10.4103/ijem.ijem_266_21 |
Ejemplares similares
-
Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives
por: Firdous, Parveena, et al.
Publicado: (2018) -
High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes
por: McDonald, Tim J., et al.
Publicado: (2011) -
Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860–1862
por: Blanco, Jesús, et al.
Publicado: (2011) -
Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860–1862
por: McDonald, Tim J., et al.
Publicado: (2011) -
Obstructive sleep apnea in Type 2 diabetes and impact of continuous positive airway pressure therapy on glycemic control
por: Malik, Javid Ahmad, et al.
Publicado: (2017)